An evaluation of the relationship between arachidonic acid lipoxygenation and human neutrophil degranulation.
D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D015117:5,8,11,14-Eicosatetraynoic Acid / Q000494:pharmacology; D001095:Arachidonic Acids / Q000096:biosynthesis / Q000378:metabolism*; D000001:Calcimycin / Q000494:pharmacology; D002855:Chromatography, Thin Layer; D003571:Cytochalasin B / Q000494:pharmacology; D003594:Cytoplasmic Granules / Q000378:metabolism*; D005966:Glucuronidase / Q000378:metabolism; D006801:Humans; D006835:Hydrazones / Q000494:pharmacology; D007700:Kinetics; D008084:Lipoxygenase / Q000096:biosynthesis / Q000378:metabolism*; D009113:Muramidase / Q000378:metabolism; D009239:N-Formylmethionine / Q000031:analogs & derivatives / Q000494:pharmacology; D009240:N-Formylmethionine Leucyl-Phenylalanine; D009504:Neutrophils / Q000378:metabolism*; D009842:Oligopeptides / Q000494:pharmacology
D001095:Arachidonic Acids; D006835:Hydrazones; D009842:Oligopeptides; C012483:phenylhydrazone; D015117:5,8,11,14-Eicosatetraynoic Acid; D000001:Calcimycin; D003571:Cytochalasin B; D009239:N-Formylmethionine; D009240:N-Formylmethionine Leucyl-Phenylalanine; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D008084:Lipoxygenase; D009113:Muramidase; D005966:Glucuronidase